// App-Quantinova.ai

9010 : Association of ALK resistance mutations by EML4-ALK variant (v3 vs. non-v3) in ALK+ non-small cell lung cancer (NSCLC).

Researchers

Presenter

  • Sai-Hong Ignatius Ou

Principal Investigators

  • Alexa Betzig Schrock

  • Kyle Gowen

  • Philip J. Stephens

  • Jeffrey S. Ross

  • Melissa Lynne Johnson

  • Christine Marie Lovly

  • Siraj Mahamed Ali

  • Vincent A. Miller

  • Alice Tsang Shaw

Medical Centers

  • University of California Irvine Health Chao Family Comprehensive Cancer Center, Orange, CA

  • Foundation Medicine, Inc, Cambridge, MA

  • Albany Medical Center, Albany, NY

  • Sarah Cannon Research Institute, Nashville, TN

  • Vanderbilt-Ingram Cancer Center, Nashville, TN

  • Massachusetts General Hospital, Boston, MA

Locations

  • United States

Companies

  • Foundation Medicine,

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved